Last reviewed · How we verify

NCT04056871

Different Frailty Scores to Incidence of Post-operative Delirium and Cognitive Dysfunction

Completed Last updated 30 April 2020
What this trial tests

trial testing Frailty Screening Tools in Frail Elderly Syndrome in 400 participants. Completed in 20 February 2020.

Timeline
20 August 2019
Primary endpoint
30 January 2020
20 February 2020

Quick facts

Lead sponsorUniversity of Malaya
StatusCompleted
Study typeOBSERVATIONAL
Enrollment400
Start date20 August 2019
Primary completion30 January 2020
Estimated completion20 February 2020
Sites1 location across Malaysia

Drugs / interventions tested

Conditions studied

Sponsor

University of Malaya

Who can join

65 and older, any sex, with Frail Elderly Syndrome or Postoperative Delirium. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients who are frail will have higher rate for post-operative morbidities, mortality, prolonged hospital stays, loss of independence, increase in institutionalization, post-operative cognitive dysfunction (POCD) and delirium (POD). So, it is crucial to find a suitable frailty assessment tool that can be incorporated into a guideline and reference for our local setting in geriatric peri-operative management. In the mean time, create awareness regarding the frailty elderly population with POD, POCD and other associated poor outcomes among our clinicians.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Frail Elderly Syndrome

Currently open trials in the same condition.

Other University of Malaya trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04056871.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing